Tempus AI acquires Personalis for $1.5 billion to expand cancer MRD testing capabilities, targeting a $20 billion market with AI-driven precision oncology.
The post Tempus AI strikes $1.5B deal for Personalis, betting big on AI-powered cancer detection appeared first on Crypto Briefing.